| Dunlap, Jaden |
| MRN: 424433 | Room: 624 | DOB: 12/25/1949 | Age: 77 | Gender: Male | Allergies: Penicillin (rash), Lisinopril (cough), Ciprofloxacin (rash) |
| Setting | Adult Medicine Unit | ||
| Scenario | Please see clinical note. Jaden Dunlap is transferred from an outside freestanding ED to a medicine ward at your hospital for a higher level of care. The internal medicine care team has ordered a regular diet during the hospital stay. As a member of the patient’s care team, please address pharmacotherapy recommendations with respect to treatment of his influenza and presumed bacterial pneumonia as well as his other disease states to optimize this patient’s care in the hospital and at discharge. | ||
| Admission note taken on 01/31/26 | |||
| CC | “I am short of breath and just don’t feel well.” | ||
| HPI | Mr. Dunlap is a 77 y.o. male who presented to an outside freestanding emergency department (ED) yesterday evening for shortness of breath, weakness, muscle aches, chills, productive cough, nausea, and lack of appetite since yesterday. He has only been able to keep down small amounts of water, tea, and electrolyte drinks. Mr. Dunlap reports he was exposed to family members who were recently diagnosed with influenza. He has not been hospitalized or received any antibiotics within the last 6 months. Mr. Dunlap was transferred to the hospital for continued management after being diagnosed with influenza A and suspected concomitant bacterial pneumonia. First doses of antimicrobials were initiated at the outside ED including oseltamivir 75 mg PO, vancomycin 1750 mg IV, and cefepime 1 gram IV, which were tolerated without any issues. | ||
| PMH |
|
||
| Social History |
|
Family History |
|
| Vaccine History |
|
Surgical History |
|
| Physical Exam |
ROS (source: patient)
|
||
| Test Name | 02/01/26 | 01/31/26 | Range |
| Sodium (Na+) | 132 | 131 | 136-145 mEq/L |
| Potassium (K+) | 4.5 | 4.7 | 3.5-5 mEq/L |
| Chloride (Cl-) | 97 | 95 | 98-106 mEq/L |
| Bicarbonate (HCO3-) | 30 | 31 | 23-28 mEq/L |
| Urea nitrogen (BUN) | 68 | 64 | 8-20 mg/dL |
| Creatinine | 13.7 | 12.9 | 0.5-1.3 mg/dL |
| Glucose | 387 | 405 | 70-115 mg/dL |
| Hemoglobin A1c | 9.1 | 5.3-7.5 % | |
| Calcium,Total | 8.7 | 8.6 | 8.6-10.2 mg/dL |
| Phosphate | 4 | 4.1 | 3-4.5 mg/dL |
| Magnesium | 1.9 | 1.8 | 1.6-2.6 mEq/L |
| Protein, total | 5.5 | 5.6 | 5.5-9 g/dL |
| Albumin | 3.2 | 3.3 | 3.5-5.5 g/dL |
| Aminotransferase,aspartate (AST) | 23 | 21 | 10-40 units/L |
| Aminotransferase,alanine (ALT) | 16 | 14 | 10-40 units/L |
| Lactic dehydrogenase (LDH) | 111 | 112 | 80-225 units/L |
| Alkaline phosphatase | 60 | 61 | 30-120 units/L |
| Bilirubin, Total | 0.7 | 0.6 | 0.3-1 mg/dL |
| Leukocytes (WBC) | 15.3 | 15.1 | 4.5-11 x103/mcL |
| Red blood cells (RBC), Male | 4.1 | 4.1 | 3.8-5.1 x108/mcL |
| Hemoglobin, Male | 10.4 | 10.5 | 14-18 g/dL |
| Hematocrit, Male | 28.3 | 29 | 42-50 % |
| Mean corpuscular hemoglobin (MCH) | 30 | 31 | 27-33 picogram |
| Mean corpuscular volume (MCV) | 82 | 82 | 76-100 mcm3 |
| Platelets | 168 | 165 | 150-450 x103/mcL |
| International normalized ratio (INR) | 1.0 | 1.1 | 0.8-1.2 |
| Prothrombin time (PT) | 11 | 11.1 | 9.5-11.3 sec |
| Partial thromboplastin time,activated (aPTT) | 33 | 33 | 25-35 sec |
| Additional Labs: |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Cultures: |
|
||||||||||||||||||||||||||||||||||||||||||||||
| Imaging Studies: |
|
| ||||||||||||||||||||||||||||||||||||||||||
| Medication History |
|
| Patient Name: Dunlap, Jaden Date of Birth: 12/25/1949 Room#: 624 |
Allergies: |
Immunization History: |
| Community Rx Info: Rx Insurance: |
Social History: |
|
| Additional Notes: | ||
STRENGTH DF |
ROUTE FREQ |
DOSE (date/time) |
EFFECTS |
ACTION |
REASON |
|||
|---|---|---|---|---|---|---|---|---|
| Action Key: C = Continue, D = Discontinue*, H = Hold*, M = Modify* *must provide reason |
||||||||
| Medication | 02/01/26 | 01/31/26 |
| Vancomycin 1,000 mg IV Pharmacy to dose Rate: 133 mL/hr | ||
| Cefepime 1,000 mg IV Q24H Rate: 100 mL/hr | 23:38 | |
| Oseltamivir 75 mg PO Q12H | ||
| Lactated Ringer’s Solution IV continuous, 100 mL/hr | ||
| Insulin aspart sliding scale SC ACHS | ||
| Heparin 5,000 units SC Q8H | ||
| Pregabalin 50 mg PO QHS | ||
| Aspirin 81 mg PO QD | ||
| Albuterol/Ipratropium 2.5 mg/0.5 mg NEB Q6H PRN PRN SOB | ||
| Acetaminophen 650 mg PO Q6H PRN PRN pain (1-4) or fever (>37.8°C) | ||
| Vancomycin 1,750 mg IV STAT x1 Rate: 175 mL/hr | 23:13 |
| Hospital Medications | ||||||
| Medication | Instructions | Comments | Continue | Modify | Discontinue | New Rx sent |
| Previous Home Medications | ||||||
| Medication | Instructions | Comments | Continue | Modify | Discontinue | New Rx sent |
| Patient Name: | ||
| Admission Date: | Discharge Date: | Service: |
| Principle Diagnosis on Admission: | ||
| Secondary Diagnosis: | ||
| Allergies: | ||
| Medications ADDED this visit: (begin taking these) |
Medications CHANGED this visit: (modify what you were taking) |
Medications STOPPED this visit: (stop taking these) |
| Final Discharge Medication List | |||||
| Medication/Route/Dosage/Frequency/Duration | Comments | Morning | Afternoon | Evening | Bedtime |
| As Needed Medications | |||||
| Patient Name: Dunlap, Jaden | Date of Birth: 12/25/1949 | Room: 624 |
| Medication (name/strength) | Dose | Route | Frequency | Notes |